Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Ocular manifestations of cryoglobulinemia: a reappraisal

Abstract

Background/Objectives

To describe frequency and type of ocular manifestations in patients with cryoglobulinemic vasculitis (CV), as well as management approaches and outcomes.

Subjects/Methods

This was a retrospective, observational, cohort study of patients who were diagnosed with CV at a single center and regularly underwent a comprehensive ocular assessment.

Results

Ophthalmologic manifestations were recorded in 16 patients (28%). The diagnoses included dry eye disease and primary Sjögren syndrome in 5 and 2 patients, respectively; peripheral ulcerative keratitis and anterior scleritis in 1 patient each; hyperviscosity syndrome and hypertensive retinopathy in 2 patients each; and Purtscher- like retinopathy in 3 patients. Twelve patients (75%) were anti-HCV/HCV RNA-positive, 11 of whom achieved a sustained virologic response (SVR) following treatment with interferon-α2b plus ribavirin or direct-acting antivirals. All patients were treated with ocular lubricants. Systemic therapeutic measures, including glucocorticoids, immunosuppressive and biologic agents, induced the disappearance or ≥50% reduction of cryoglobulins and major signs of vasculitis in 11 patients (68.7%). In the remaining 5 patients (31.3%), cryoglobulins and CV manifestations remained unchanged or decreased by <50%. The corresponding ophthalmologic assessment showed a variable degree of improvement in the ocular symptoms in all but 2 patients (87.5%). The best corrected visual acuity following treatment improved in 26 eyes, was unchanged in 3 eyes, and worsened in 3 eyes.

Conclusions

Eye involvement is not a rare event in CV patients. A timely diagnosis and the correct employment of the available therapeutic measures may result in a favorable outcome of the ocular and extra-ocular manifestations.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Clinical evolution of anterior scleritis associated with Purpura Arthralgia Weakness Mixed Cryoglobulinemia Syndrome.
Fig. 2: Typical images of Purtscher-like retinopathy.

Similar content being viewed by others

Data availability

Data are available upon request and are with the corresponding author. The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M. Biologic and clinical significance of cryoglobulins. A report of 86 cases. Am J Med. 1974;57:775–88.

    Article  CAS  PubMed  Google Scholar 

  2. Roccatello D, Saadoun D, Ramos-Casals M, Tzioufas AG, Fervenza FC, Cacoub P, et al. Cryoglobulinaemia. Nat Rev Dis Prim. 2018;4:11.

    Article  PubMed  Google Scholar 

  3. Dammacco F, Lauletta G, Russi S, Leone P, Tucci M, Manno C, et al. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clin Exp Med. 2019;19:1–21.

    Article  CAS  PubMed  Google Scholar 

  4. Meltzer M, Franklin EC. Cryoglobulinemia–a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med. 1966;40:828–36.

    Article  CAS  PubMed  Google Scholar 

  5. Meltzer M, Franklin EC, Elias K, McCluskey RT, Cooper N. Cryoglobulinemia–a clinical and laboratory study. II. Cryoglobulins with rheumatoid factor activity. Am J Med. 1966;40:837–56.

    Article  CAS  PubMed  Google Scholar 

  6. Ferri C, Greco F, Longombardo G, Palla P, Moretti A, Marzo E, et al. Antibodies against hepatitis C virus in mixed cryoglobulinemia patients. Infection 1991;19:417–20.

    Article  CAS  PubMed  Google Scholar 

  7. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med. 1992;327:1490–5.

    Article  CAS  PubMed  Google Scholar 

  8. Dammacco F, Sansonno D. Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia. Clin Exp Immunol 1992;87:352–6.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Trejo O, Ramos-Casals M, García-Carrasco M, Yagüe J, Jiménez S, de la Red G, et al. Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center. Medicine. 2001;80:252–62.

    Article  CAS  PubMed  Google Scholar 

  10. Terrier B, Marie I, Lacraz A, Belenotti P, Bonnet F, Chiche L, et al. Non HCV-related infectious cryoglobulinemia vasculitis: results from the French nationwide CryoVas survey and systematic review of the literature. J Autoimmun. 2015;65:74–81.

    Article  PubMed  Google Scholar 

  11. Galli M, Oreni L, Saccardo F, Castelnovo L, Filippini D, Marson P, et al. HCV-unrelated cryoglobulinaemic vasculitis: the results of a prospective observational study by the Italian Group for the Study of Cryoglobulinaemias (GISC). Clin Exp Rheumatol. 2017;35:67–76.

    PubMed  Google Scholar 

  12. European Association for the Study of the Liver. EASL recommendations on treatment of hepatitis C: final update of the series. J Hepatol. 2020;73:1170–218.

  13. Boleto G, Ghillani-Dalbin P, Musset L, Biard L, Mulier G, Cacoub P, et al. Cryoglobulinemia after the era of chronic hepatitis C infection. Semin Arthritis Rheum. 2020;50:695–700.

    Article  CAS  PubMed  Google Scholar 

  14. Dammacco F, Lauletta G, Vacca A. The wide spectrum of cryoglobulinemic vasculitis and an overview of therapeutic advancements. Clin Exp Med. 2023;23:255–72.

  15. Ferri C, Sebastiani M, Giuggioli D, Cazzato M, Longombardo G, Antonelli A, et al. Mixed cryoglobulinemia: demographic, clinical, and serologic features and survival in 231 patients. Semin Arthritis Rheum. 2004;33:355–74.

    Article  PubMed  Google Scholar 

  16. Ramos-Casals M, Stone JH, Cid MC, Bosch X. The cryoglobulinaemias. Lancet. 2012;379:348–60.

    Article  CAS  PubMed  Google Scholar 

  17. Sebastiani M, Giuggioli D, Colaci M, Fallahi P, Gragnani L, Antonelli A, et al. HCV441 related rheumatic manifestations and therapeutic strategies. Curr Drug Targets. 2017;18:803–10.

    Article  CAS  PubMed  Google Scholar 

  18. Mazzaro C, Quartuccio L, Adinolfi LE, Roccatello D, Pozzato G, Nevola R, et al. A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy. Viruses. 2021;13:2249.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Mazzaro C, Dal Maso L, Mauro E, Gattei V, Ghersetti M, Bulian P, et al. Survival and prognostic factors in mixed cryoglobulinemia: data from 246 cases. Diseases. 2018;6:35.

    Article  PubMed  PubMed Central  Google Scholar 

  20. Dammacco F, Sansonno D. Therapy for hepatitis C virus-related cryoglobulinemic vasculitis. N Engl J Med. 2013;369:1035–45.

    Article  CAS  PubMed  Google Scholar 

  21. Saadoun D, Landau DA, Calabrese LH, Cacoub PP. Hepatitis C-associated mixed cryoglobulinaemia: a crossroad between autoimmunity and lymphoproliferation. Rheumatology. 2007;46:1234–42.

    Article  CAS  PubMed  Google Scholar 

  22. Chiu CY, Cheng CK. Synergic effect of intravitreal bevacizumab and systemic corticosteroid in treating systemic inflammatory response syndrome (SIRS) associated purtscher-like retinopathy. Ocul Immunol Inflamm. 2023;31:421–5.

  23. Ramos-Casals M, Solans R, Rosas J, Camps MT, Gil A, Del Pino-Montes J, et al. GEMESS Study Group. Primary Sjögren syndrome in Spain: clinical and immunologic expression in 1010 patients. Medicine. 2008;87:210–9.

    Article  CAS  PubMed  Google Scholar 

  24. Argyropoulou OD, Pezoulas V, Chatzis L, Critselis E, Gandolfo S, Ferro F, et al. Cryoglobulinemic vasculitis in primary Sjögren’s Syndrome: clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease. Semin Arthritis Rheum. 2020;50:846–53.

    Article  CAS  PubMed  Google Scholar 

  25. Kedhar SR, Belair ML, Jun AS, Sulkowski M, Thorne JE. Scleritis and peripheral ulcerative keratitis with hepatitis C virus-related cryoglobulinemia. Arch Ophthalmol. 2007;125:852–3.

    Article  PubMed  Google Scholar 

  26. Johnson CC, Ohlstein DH. Peripheral ulcerative keratitis and necrotizing scleritis initiated by trauma in the setting of mixed cryoglobulinemia. Case Rep Ophthalmol. 2011;2:392–7.

    Article  PubMed  PubMed Central  Google Scholar 

  27. Coelho P, Menezes C, Gonçalves R, Rodrigues P, Seara E. Peripheral ulcerative keratitis associated with HCV-related cryoglobulinemia. Case Rep Ophthalmol Med. 2017;2017:9461937.

    PubMed  PubMed Central  Google Scholar 

  28. Aiello F, Congliaro P, Malaspina C, Gallo Afflitto G, Nucci C. Peripheral ulcerative keratitis as the primary clinical manifestation of type 2 cryoglobulinemia. Can J Ophthalmol. 2021;56:e148–e150.

    Article  PubMed  Google Scholar 

  29. Wei DW, Pagnoux C, Chan CC. Peripheral ulcerative keratitis secondary to chronic hepatitis B infection. Cornea. 2017;36:515–7.

    Article  PubMed  Google Scholar 

  30. Doguizi S, Sekeroglu MA, Anayol MA, Yilmazbas P. A rare cause of unilateral central retinal vein occlusion in a young patient: type III mixed cryoglobulinemia. Case Rep Ophthalmol Med. 2016;2016:1949362.

    PubMed  PubMed Central  Google Scholar 

  31. Sebrow DB, Jung JJ, Horowitz J, Odel JG, Freund KB. Macular perivenous retinal whitening and presumed retino-ciliary sparing in a recurrent central retinal vein occlusion associated with the antiphospholipid syndrome and cryoglobulinemia. Retin Cases Brief Rep. 2018;12:159–165.

    Article  PubMed  Google Scholar 

  32. Takkar B, Azad SV, Kumar U, Venkatesh P. Extensive choroidal infarction in a case of mixed essential cryoglobulinaemia in a postpartum female. BMJ Case Rep. 2016;2016:bcr2016216513.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Salah S Jr, Imbeau L Jr, Le Lez ML, Regina S, Lioger B. Scleritis and retinal vasculitis associated with a type II mixed cryoglobulinemia. QJM. 2014;107:585–6.

    Article  PubMed  Google Scholar 

  34. Telander DG, Holland GN, Wax MB, Van Gelder RN. Rubeosis and anterior segment ischemia associated with systemic cryoglobulinemia. Am J Ophthalmol. 2006;142:689–90.

    Article  PubMed  Google Scholar 

  35. Cohen SM, Kokame GT, Gass JD. Paraproteinemias associated with serous detachments of the retinal pigment epithelium and neurosensory retina. Retina 1996;16:467–73.

    Article  CAS  PubMed  Google Scholar 

  36. Zamir E, Chowers I. Central serous chorioretinopathy in a patient with cryoglobulinaemia. Eye. 1999;13:265–6.

    Article  PubMed  Google Scholar 

  37. Myers JP, Di Bisceglie AM, Mann ES. Cryoglobulinemia associated with Purtscher like retinopathy. Am J Ophthalmol. 2001;131:802–4.

    Article  CAS  PubMed  Google Scholar 

  38. Sauer A, Nasica X, Zorn F, Petitjean P, Bader P, Speeg-Schatz C, et al. Cryoglobulinemia revealed by a Purtscher-like retinopathy. Clin Ophthalmol. 2007;1:555–7.

    PubMed  PubMed Central  Google Scholar 

  39. Chebil A, Mammouri R, Abdallah MB, El Matri L. Purtscher-like retinopathy as a rare presentation of cryoglobulinemia. Middle East Afr J Ophthalmol. 2016;23:219–21.

    Article  PubMed  PubMed Central  Google Scholar 

  40. Cirasino L, Guatteri A, Sandri L, Baudo F, Silvani A, Morra E. Linfoma MALT delle ghiandole lacrimale e mammaria di sinistra, cirrosi epatica da HCV e crioglobulinemia di tipo II [MALT lymphoma of the left lacrimal and mammary glands, liver cirrhosis caused by HCV and type II cryoglobulinemia]. Recent Prog Med. 1998;89:79–81.

    CAS  Google Scholar 

  41. Donders PC. Clinical demonstrations: ophthalmological phenomena in Waldenström’s disease with cryoglobulinaemia. Ophthalmologica. 1958;135:324–6.

    Article  CAS  PubMed  Google Scholar 

  42. Ferri C, Mannini L, Bartoli V, Gremignai G, Genovesi-Ebert F, Cristofani R, et al. Blood viscosity and filtration abnormalities in mixed cryoglobulinemia patients. Clin Exp Rheumatol. 1990;8:271–81.

    CAS  PubMed  Google Scholar 

  43. Cacoub P, Renou C, Rosenthal E, Cohen P, Loury I, Loustaud-Ratti V, et al. Extrahepatic manifestations associated with hepatitis C virus infection. A prospective multicenter study of 321 patients. The GERMIVIC. Groupe d’Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l’Hepatite C. Medicine. 2000;79:47–56.

    Article  CAS  PubMed  Google Scholar 

  44. Pawlotsky JM, Ben Yahia M, Andre C, Voisin MC, Intrator L, Roudot-Thoraval F, et al. Immunological disorders in C virus chronic active hepatitis: a prospective case control study. Hepatology. 1994;19:841–8.

    Article  CAS  PubMed  Google Scholar 

  45. Siagris D, Pharmakakis N, Christofidou M, Petropoulos JK, Vantzou C, Lekkou A, et al. Keratoconjunctivitis sicca and chronic HCV infection. Infection. 2002;30:229–33.

    Article  CAS  PubMed  Google Scholar 

  46. Verbaan H, Carlson J, Eriksson S, Larsson A, Liedholm R, Manthorpe R, et al. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren’s syndrome and hepatitis C in Swedish patients. J Intern Med. 1999;245:127–32.

    Article  CAS  PubMed  Google Scholar 

  47. Tripathy K, Patel BC. Purtscher retinopathy. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2022.

  48. Emery JS, Kuczynski M, La D, Almarzooqi S, Kowgier M, Shah H, et al. Efficacy and safety of direct acting antivirals for the treatment of mixed cryoglobulinemia. Am J Gastroenterol. 2017;112:1298–1308.

    Article  CAS  PubMed  Google Scholar 

  49. Gragnani L, Visentini M, Fognani E, Urraro T, De Santis A, Petraccia L, et al. Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia. Hepatology. 2016;64:1473–82.

    Article  CAS  PubMed  Google Scholar 

  50. Sansonno D, Dammacco F. Hepatitis C virus, cryoglobulinaemia, and vasculitis: immune complex relations. Lancet Infect Dis. 2005;5:227–36.

    Article  PubMed  Google Scholar 

  51. Gross WL. New concepts in treatment protocols for severe systemic vasculitis. Curr Opin Rheumatol. 1999;11:41–6.

    Article  CAS  PubMed  Google Scholar 

  52. Galli M, Monti G, Marson P, Scaini P, Pietrogrande M, Candela M, et al. Recommendations for managing the manifestations of severe and life-threatening mixed cryoglobulinemia syndrome. Autoimmun Rev. 2019;18:778–85.

    Article  PubMed  Google Scholar 

  53. Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, et al. Pegylated interferon-alpha, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood 2010;116:343–53.

    Article  CAS  PubMed  Google Scholar 

  54. Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmun Rev. 2011;11:48–55.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

RD, GA and FD conceived and designed the study, retrieved, collected and had full access to all the data in the study, and take responsibility for the integrity of the data and the accuracy of the analysis. RD wrote the manuscript. LC and LDS revised the manuscript for important intellectual content and supplied additional images of Purtscher like retinopathy. All authors reviewed the manuscript, approved the draft submission, and accept responsibility for all aspects of this study.

Corresponding author

Correspondence to Rosanna Dammacco.

Ethics declarations

Competing interests

RD, LC, LDS, GA and FD certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers’ bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent-licensing arrangements), or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge or beliefs) in the subject matter or materials.

Ethical approval and consent to participate

All research and measurements adhered to the tenets of the Declaration of Helsinki.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dammacco, R., Cimino, L., De Simone, L. et al. Ocular manifestations of cryoglobulinemia: a reappraisal. Eye 38, 585–593 (2024). https://doi.org/10.1038/s41433-023-02738-y

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41433-023-02738-y

Search

Quick links